Comparative Effectiveness of an mTOR-Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple-Negative Breast Cancer.
Basho, Reva K
Comparative Effectiveness of an mTOR-Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple-Negative Breast Cancer. [electronic resource] - The oncologist 11 2018 - 1300-1309 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1549-490X
10.1634/theoncologist.2017-0498 doi
Adult
Aged
Female
Humans
Middle Aged
Prognosis
TOR Serine-Threonine Kinases--genetics
Triple Negative Breast Neoplasms--drug therapy
Comparative Effectiveness of an mTOR-Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple-Negative Breast Cancer. [electronic resource] - The oncologist 11 2018 - 1300-1309 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1549-490X
10.1634/theoncologist.2017-0498 doi
Adult
Aged
Female
Humans
Middle Aged
Prognosis
TOR Serine-Threonine Kinases--genetics
Triple Negative Breast Neoplasms--drug therapy